Telix Pharmaceuticals acquires ITM
Radioisotopes and radiopharmaceuticals · München, Germanyacquired byTelix Pharmaceuticals
advised by
- Sell-side
- Latham & Watkins
- Buy-side
- Centerview Partners(M&A)Morgan Stanley(M&A)Sidley Austin(Recht)
The Australian company Telix Pharmaceuticals acquires Isotope Technologies Munich in full, at an EV of $1.65bn plus an earn-out of up to $700m. Completion is subject to approval by Telix shareholders.
- Buyer
- Telix Pharmaceuticals
- Target
- ITM, München
- Type
- Strategic
- Sector
- Healthcare & Medtech
- Country
- Germany
- First reported
- 21/09/2026
- Sell-side
- Latham & Watkins, according to the source
- Buy-side
- Centerview Partners, Morgan Stanley, Sidley Austin, according to the source
- Source
- AuntMinnie Europe
Deal-Radar no. 42-128 · added in Week 42/2026, first reported on 21/09/2026 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by Telix Pharmaceuticals
So far this is the only transaction by Telix Pharmaceuticals published in the Deal-Radar. New deals are added every Monday.
Strategic and succession in Week 42/2026
All deals in September 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 19 October 2026.